Market Cap 21.86M
Revenue (ttm) 26.55M
Net Income (ttm) -91.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -345.46%
Debt to Equity Ratio -1.26
Volume 17,848
Avg Vol 183,016
Day's Range N/A - N/A
Shares Out 28.95M
Stochastic %K 60%
Beta 0.54
Analysts Sell
Price Target $6.00

Company Profile

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and deg...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 768 2170
Address:
170 Park Avenue, Florham Park, United States
luckydog2
luckydog2 Jul. 15 at 6:18 PM
$CELU Milestone Moment For Fontaine Vitale Clinic It won't be long before it's up and running. https://www.reddit.com/r/CelularityNews/s/Z3WuFaARQV
0 · Reply
NuclearMan
NuclearMan Jul. 15 at 12:39 PM
$CELU By 28 July, Bob must file a 10Q or present Nasdaq with a plan to file a 10Q. If Bob fails to file a plan, the stock will be delisted. If Bob argues that he did not have the funding to file a 10Q, then his letter on 3 June is a "material misrepresentation" of the business and therefore fraud. The untapped ATM (see prev( and 1m/1month loan adds to the fishiness. I lnow I have been harping on about a 10Q but this is a genuine existential threat. I can't believe Hariri is a scammer, but the delay makes zero sense now. If he pulls a rabbit out of the hat, I will stand corrected obvs.
1 · Reply
NuclearMan
NuclearMan Jul. 15 at 12:11 PM
$CELU In early May 2026, this company was compliant on all fronts. At that point, given its cash situation, it could have exercised the existing ATM agreement it has in place to fund operations. It chose not to do so. It is now noncompliant and the ATM cannot be accessed. It retired all debt but has a cash runway of zero- needing a loan from Barach that is timed to default the day AFTER the 28 July deadline for filing a 10Q. This goes one of two ways, depending on if CELU has a rabbit to pull out of the hat. But if Bob lets the company default and bankrupt on 29 July, he has questions to answer.
0 · Reply
NuclearMan
NuclearMan Jul. 14 at 3:25 PM
$CELU FWIW I have been asking Gemini Pro to estimate the financials. It is a mixed bag. It says the Nexgel money has been allocated to paying off debt. It says future Nexgel money is going to pay off the Helena convertible note. It says the current $1M loan expires the day AFTER the Nasdaq deadline for filing a 10Q on 28 July. It says the trial costs are likely complete. But Barach holds first priority over the assets and IP. But adds that Bob *is* the IP and his common stock is in the toilet at a 1.60 average. It says the monies for paying CFOSquad should be there and the delay to the 10Q is likely an issue around the classification of remaining debt. BUT despite all that Gemini cannot explain why Bob took out a 1m loan, which deprioritises Hariri in the debt hierarchy.
0 · Reply
Nosay
Nosay Jul. 14 at 1:36 PM
$CELU another day and another nothing. Q2 is complete now. Only 31 days till those numbers are due and we’re still waiting for Q1. Things are obviously happening. 2 accounting jobs posted in their site. Both with salaries over 100k. Also that 30 day loan from Barach. Wtf was that? 15 days until maturity. But who risks 1 million for 4% interest over 1 month (only gaining 3300$!) if they don’t know something good is in the works. But also. Where did all the Nexgel deals money go? Why did they need 1 million. So many questions and absolute silence from the company.
1 · Reply
NuclearMan
NuclearMan Jul. 13 at 11:33 AM
$CELU Accounting for public holidays, the final day for this stock to close over a dollar and regain compliance is Monday 20th July. After that point, the stock must close over a dollar for ten consecutive days. This means that if it does not close over a dollar on or before 20th July, it is *guaranteed* to enter its Nasdaq panel deadline (for the late 10Q) as delinquent on minimum bid, MVLS and late filing of a 10Q. Not sure what Hariri or Barach are doing, but this is serious now.
0 · Reply
mf3rs
mf3rs Jul. 10 at 3:24 PM
$CELU how long before we get the delisting notice?
2 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jul. 9 at 9:13 PM
$CELU Any thoughts why 210,000 warrants were traded today when they expire in a week?
2 · Reply
Dtradeyou1
Dtradeyou1 Jul. 7 at 10:31 AM
$CELU I'm in it for the stem cells.
0 · Reply
GreatGP
GreatGP Jul. 7 at 2:19 AM
$CELU only reason to be here is for future shareholders lawsuit. Long term sec issues.
0 · Reply
Latest News on CELU
Celularity Releases CEO Letter to Shareholders

Jun 3, 2026, 4:15 PM EDT - 5 weeks ago

Celularity Releases CEO Letter to Shareholders


Celularity Appoints Rick Gonzalez as Chief Commercial Officer

Jun 3, 2026, 8:00 AM EDT - 6 weeks ago

Celularity Appoints Rick Gonzalez as Chief Commercial Officer


Celularity Receives Nasdaq Notice Regarding Form 10-Q

May 29, 2026, 5:15 PM EDT - 6 weeks ago

Celularity Receives Nasdaq Notice Regarding Form 10-Q


Celularity Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 2 months ago

Celularity Annual report: Q4 2025


NEXGEL Appoints Ian Blackman as Chief Financial Officer

Apr 27, 2026, 9:00 AM EDT - 2 months ago

NEXGEL Appoints Ian Blackman as Chief Financial Officer


NexGel closes acquisition of products from Celularity

2026-04-21T15:06:20.000Z - 3 months ago

NexGel closes acquisition of products from Celularity

NXGL


Celularity announces closing of transaction with NexGel

2026-04-21T13:07:46.000Z - 3 months ago

Celularity announces closing of transaction with NexGel


Celularity Announces Closing of Transaction with NexGel

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Celularity Announces Closing of Transaction with NexGel


Celularity secures $35M strategic license deal

2026-03-10T12:41:03.000Z - 4 months ago

Celularity secures $35M strategic license deal


Celularity Registration statement: Registration Filing

Dec 31, 2025, 7:00 AM EST - 7 months ago

Celularity Registration statement: Registration Filing


Celularity Announces Closing of Financing Transactions

Dec 22, 2025, 4:01 PM EST - 7 months ago

Celularity Announces Closing of Financing Transactions


Celularity Registration statement: Registration Filing

Dec 19, 2025, 7:00 AM EST - 7 months ago

Celularity Registration statement: Registration Filing


Celularity announces up to $12M of capital from Philip Barach

2025-12-18T19:15:11.000Z - 7 months ago

Celularity announces up to $12M of capital from Philip Barach


Celularity Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 8 months ago

Celularity Quarterly report: Q3 2025


Celularity Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 8 months ago

Celularity Proxy statement: Proxy Filing


Celularity Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 8 months ago

Celularity Proxy statement: Proxy Filing


Celularity announces publication of Phase 2 study on PDA-002

2025-10-14T12:55:36.000Z - 9 months ago

Celularity announces publication of Phase 2 study on PDA-002


Celularity reports Q1 EPS (84c) vs ($1.03) last year

2025-09-03T12:10:50.000Z - 11 months ago

Celularity reports Q1 EPS (84c) vs ($1.03) last year


Celularity regains compliance with Nasdaq listing rule

2025-09-03T12:10:44.000Z - 11 months ago

Celularity regains compliance with Nasdaq listing rule


Celularity Quarterly report: Q2 2025

Aug 29, 2025, 9:30 AM EDT - 11 months ago

Celularity Quarterly report: Q2 2025


Celularity Quarterly report: Q1 2025

Aug 29, 2025, 12:00 AM EDT - 11 months ago

Celularity Quarterly report: Q1 2025


Celularity receives noncompliance notice from Nasdaq

2025-08-22T21:35:07.000Z - 11 months ago

Celularity receives noncompliance notice from Nasdaq


Celularity Announces Chief Financial Officer Transition

Jun 10, 2025, 4:15 PM EDT - 1 year ago

Celularity Announces Chief Financial Officer Transition


Celularity Earnings release: Q4 2024

May 9, 2025, 4:00 PM EDT - 1 year ago

Celularity Earnings release: Q4 2024


Celularity Annual report: Q4 2024

May 9, 2025, 4:00 PM EDT - 1 year ago

Celularity Annual report: Q4 2024


Celularity Registration statement: Registration Filing

Feb 13, 2025, 7:00 AM EST - 1 year ago

Celularity Registration statement: Registration Filing


Celularity Registration statement: Registration Filing

Jan 30, 2025, 7:00 AM EST - 1 year ago

Celularity Registration statement: Registration Filing


Celularity Quarterly report: Q3 2024

Dec 5, 2024, 6:00 PM EST - 1 year ago

Celularity Quarterly report: Q3 2024


Celularity Inc. Announces Receipt of Nasdaq Notification

Nov 27, 2024, 5:00 PM EST - 1 year ago

Celularity Inc. Announces Receipt of Nasdaq Notification


Celularity Proxy statement: Proxy Filing

Nov 19, 2024, 7:00 AM EST - 1 year ago

Celularity Proxy statement: Proxy Filing


Celularity Quarterly report: Q2 2024

Nov 6, 2024, 6:00 PM EST - 1 year ago

Celularity Quarterly report: Q2 2024


Celularity Quarterly report: Q1 2024

Oct 16, 2024, 3:30 AM EDT - 1 year ago

Celularity Quarterly report: Q1 2024


Celularity Appoints Richard J. Berman to its Board of Directors

Aug 28, 2024, 4:45 PM EDT - 2 years ago

Celularity Appoints Richard J. Berman to its Board of Directors


Celularity Annual report: Q4 2023

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Celularity Annual report: Q4 2023


Celularity Transcript: Analyst Research & Development Day 2024

May 21, 2024, 12:00 PM EDT - 2 years ago

Celularity Transcript: Analyst Research & Development Day 2024


Celularity Slides: FY 2024

May 21, 2024, 12:00 PM EDT - 2 years ago

Celularity Slides: FY 2024


luckydog2
luckydog2 Jul. 15 at 6:18 PM
$CELU Milestone Moment For Fontaine Vitale Clinic It won't be long before it's up and running. https://www.reddit.com/r/CelularityNews/s/Z3WuFaARQV
0 · Reply
NuclearMan
NuclearMan Jul. 15 at 12:39 PM
$CELU By 28 July, Bob must file a 10Q or present Nasdaq with a plan to file a 10Q. If Bob fails to file a plan, the stock will be delisted. If Bob argues that he did not have the funding to file a 10Q, then his letter on 3 June is a "material misrepresentation" of the business and therefore fraud. The untapped ATM (see prev( and 1m/1month loan adds to the fishiness. I lnow I have been harping on about a 10Q but this is a genuine existential threat. I can't believe Hariri is a scammer, but the delay makes zero sense now. If he pulls a rabbit out of the hat, I will stand corrected obvs.
1 · Reply
NuclearMan
NuclearMan Jul. 15 at 12:11 PM
$CELU In early May 2026, this company was compliant on all fronts. At that point, given its cash situation, it could have exercised the existing ATM agreement it has in place to fund operations. It chose not to do so. It is now noncompliant and the ATM cannot be accessed. It retired all debt but has a cash runway of zero- needing a loan from Barach that is timed to default the day AFTER the 28 July deadline for filing a 10Q. This goes one of two ways, depending on if CELU has a rabbit to pull out of the hat. But if Bob lets the company default and bankrupt on 29 July, he has questions to answer.
0 · Reply
NuclearMan
NuclearMan Jul. 14 at 3:25 PM
$CELU FWIW I have been asking Gemini Pro to estimate the financials. It is a mixed bag. It says the Nexgel money has been allocated to paying off debt. It says future Nexgel money is going to pay off the Helena convertible note. It says the current $1M loan expires the day AFTER the Nasdaq deadline for filing a 10Q on 28 July. It says the trial costs are likely complete. But Barach holds first priority over the assets and IP. But adds that Bob *is* the IP and his common stock is in the toilet at a 1.60 average. It says the monies for paying CFOSquad should be there and the delay to the 10Q is likely an issue around the classification of remaining debt. BUT despite all that Gemini cannot explain why Bob took out a 1m loan, which deprioritises Hariri in the debt hierarchy.
0 · Reply
Nosay
Nosay Jul. 14 at 1:36 PM
$CELU another day and another nothing. Q2 is complete now. Only 31 days till those numbers are due and we’re still waiting for Q1. Things are obviously happening. 2 accounting jobs posted in their site. Both with salaries over 100k. Also that 30 day loan from Barach. Wtf was that? 15 days until maturity. But who risks 1 million for 4% interest over 1 month (only gaining 3300$!) if they don’t know something good is in the works. But also. Where did all the Nexgel deals money go? Why did they need 1 million. So many questions and absolute silence from the company.
1 · Reply
NuclearMan
NuclearMan Jul. 13 at 11:33 AM
$CELU Accounting for public holidays, the final day for this stock to close over a dollar and regain compliance is Monday 20th July. After that point, the stock must close over a dollar for ten consecutive days. This means that if it does not close over a dollar on or before 20th July, it is *guaranteed* to enter its Nasdaq panel deadline (for the late 10Q) as delinquent on minimum bid, MVLS and late filing of a 10Q. Not sure what Hariri or Barach are doing, but this is serious now.
0 · Reply
mf3rs
mf3rs Jul. 10 at 3:24 PM
$CELU how long before we get the delisting notice?
2 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jul. 9 at 9:13 PM
$CELU Any thoughts why 210,000 warrants were traded today when they expire in a week?
2 · Reply
Dtradeyou1
Dtradeyou1 Jul. 7 at 10:31 AM
$CELU I'm in it for the stem cells.
0 · Reply
GreatGP
GreatGP Jul. 7 at 2:19 AM
$CELU only reason to be here is for future shareholders lawsuit. Long term sec issues.
0 · Reply
topstockalerts
topstockalerts Jul. 6 at 9:41 PM
Top Gainers PT2 $INLF $SBEV $SEER $WBX $CELU
0 · Reply
Dtradeyou1
Dtradeyou1 Jul. 6 at 6:21 PM
$CELU Locked and loaded!
0 · Reply
Dtradeyou1
Dtradeyou1 Jul. 6 at 4:59 PM
$CELU Keep this on the down low. I need to buy up a little more on sale.
3 · Reply
SkywalkerAR
SkywalkerAR Jul. 6 at 3:48 PM
$CELU any news?
0 · Reply
Nosay
Nosay Jul. 3 at 3:54 PM
$CELU last year Q1 and Q2 both came out late on the same day August 29th. The stock price had been doing well and the market obviously did not like the earnings. Hopefully this year is the exact opposite. Our Q1 and Q2 can’t be worse than last year. Likely this won’t run until those numbers come out. I expect guidance for 2nd half to be very good as well.
2 · Reply
NuclearMan
NuclearMan Jul. 2 at 11:09 AM
$CELU This company has USD7.8m on the books but Barach holds the keys. He is loaning liquidity so that Bob has a bridge. The 8K was at the termination of a descending wedge so there is some method in this. Still needs the delinquent 10Q, though. Algos won't buy without it.
1 · Reply
1948Je
1948Je Jun. 30 at 10:31 PM
$CELU Every stocks run a few hundred percent, Our time will be soon
0 · Reply
Nosay
Nosay Jun. 30 at 8:23 PM
$CELU why only 1 million. And why is Phillip Barach willing to offer 4% interest. He’s lending 1 million and only collecting 3333 off of it. That’s not a big reward. Something is coming within the month for sure.
1 · Reply
focafoca99
focafoca99 Jun. 30 at 1:28 PM
$CELU took a $1 million loan from the Barach Family Trust, 4% interest, maturing 30 days after closing or receipt of financing.
0 · Reply
NuclearMan
NuclearMan Jun. 30 at 12:54 PM
$CELU Financials for this company may not be bad now. They have USD7.8M cash and retired most outstanding debt. Their remaining liabilities are USD7M to Barach plus factory operating costs (which should be offset by the ongoing Nexgel deal). This is all guestimates though, based on the 10K and applying recent data to that. But the market won't recognise any improvements unless Bob files the numbers. This is why his shareholder letter was ignored by algos.
0 · Reply
NuclearMan
NuclearMan Jun. 30 at 12:36 PM
$CELU Celularity has until 28 July to file the 10Q. It goes delinquent on minimum bid in eleven trading days. So given the rules that kick in after 30 days under a dollar, Celularity will face a panel for the 10Q while also delinquent on MVLS *and* the minimum bid. My guess is the auditors have an issue with the classification of Barach's position, but whatever the reason, the missing 10Q is of critical importance to the company staying listed.
0 · Reply
wolf_of_crypto_street
wolf_of_crypto_street Jun. 30 at 12:28 PM
$CELU this shit is headed to zero
0 · Reply